Einat Brill Almon, VP, Product Development at Protalix BioTherapeutics, Inc. (PLX), sold 59,822 shares at $5.13 ($304K) on 2009-07-06, disclosed to the SEC on 2009-07-08.
Scheduled sale ($304k) by VP, Product Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.13 | 44,000 | $226K | 74.2% |
| 2 | $4.95 | 4,822 | $24K | 7.9% |
| 3 | $4.95 | 11,000 | $54K | 17.9% |
| Total | $5.08 avg | 59,822 | $304K | 100% |
| Filing → |
| PLX | SELL | 2010-09-08 | $404K | — | Filing → |
| PLX | SELL | 2009-10-19 | $847K | — | Filing → |
| PLX | SELL | 2009-05-19 | $160K | — | Filing → |